These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3560779)

  • 21. Present and future treatment of peptic ulcer and potential role of DE-NOL.
    Scand J Gastroenterol Suppl; 1982; 80():49-57. PubMed ID: 6761852
    [No Abstract]   [Full Text] [Related]  

  • 22. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems associated with medical treatment of peptic ulcer disease.
    Zimmerman TW
    Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Adverse effects of drugs acting on the upper digestive system: anti-ulcer agents and modifiers of motoricity].
    Blanchi A
    Ann Gastroenterol Hepatol (Paris); 1984 Dec; 20(6):371-3. PubMed ID: 6549432
    [No Abstract]   [Full Text] [Related]  

  • 25. Sucralfate, bismuth subcitrate, and gastric HCO3 in humans.
    Guslandi M
    Gut; 1990 Aug; 31(8):958-9. PubMed ID: 2387525
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of De-Nol].
    Tomecki R; Habior A; Medrzejewski W
    Pol Tyg Lek; 1984 Sep; 39(37):1247-8. PubMed ID: 6390386
    [No Abstract]   [Full Text] [Related]  

  • 27. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacological effect and clinical application of protective agents of gastric mucosa].
    Si JM; Wang CJ; Wu JG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2955-7. PubMed ID: 18261319
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
    Kauffman GL
    J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of peptic ulcer.
    Barbezat GO
    N Z Med J; 1982 Nov; 95(720):813-4. PubMed ID: 6961321
    [No Abstract]   [Full Text] [Related]  

  • 31. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
    Guslandi M
    Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456
    [No Abstract]   [Full Text] [Related]  

  • 32. Double blind randomised study of tripotassium-di-citrato-bismuthate in the treatment of peptic ulcer.
    Tripathi BM; Misra NP; Dube S
    J Assoc Physicians India; 1984 Nov; 32(11):964-5. PubMed ID: 6396295
    [No Abstract]   [Full Text] [Related]  

  • 33. De-Nol: a new concept in cytoprotection. Proceedings from an international symposium. Milan, Italy, 13 November 1985.
    Scand J Gastroenterol Suppl; 1986; 122():1-53. PubMed ID: 3465025
    [No Abstract]   [Full Text] [Related]  

  • 34. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytoprotection and stress ulceration.
    Pilchman J; Lefton HB; Braden GL
    Med Clin North Am; 1991 Jul; 75(4):853-63. PubMed ID: 2072791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in ulcer therapy].
    Domschke W
    Fortschr Med; 1983 Apr; 101(13):575-82. PubMed ID: 6133827
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is bismuth subcitrate an effective drug for the patient with peptic ulcer?].
    Brouwers JR; Tytgat GN
    Ned Tijdschr Geneeskd; 1982 May; 126(18):795-8. PubMed ID: 7088206
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of gastrointestinal bleeding during mechanical ventilation.
    Offenstadt G; Guidet B; Maury E
    N Engl J Med; 1998 Jul; 339(4):267; author reply 267-8. PubMed ID: 9687249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.